BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

  September 9, 2025

   · 

  9 min read
• Press Releases

  Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering

  September 9, 2025

   · 

  5 min read
• Press Releases

  Rapport Announces Pricing of Public Offering of Common Stock

  September 9, 2025

   · 

  5 min read
• Press Releases

  Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

  September 9, 2025

   · 

  1 min read
• Press Releases

  PhotonPharma Inc. Receives U.S. Patent for Innovative Cancer Immunotherapy

  September 9, 2025

   · 

  3 min read
• Press Releases

  AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

  September 9, 2025

   · 

  15 min read
• Press Releases

  Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

  September 9, 2025

   · 

  3 min read
• Press Releases

  Corner Therapeutics Research Opens Path to Universal, Long-Lasting Flu Vaccine and Signals Promise for Oncology

  September 9, 2025

   · 

  2 min read
• Press Releases

  Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

  September 9, 2025

   · 

  10 min read
• Press Releases

  Bicycle Therapeutics Strengthens Board of Directors with New Appointments

  September 9, 2025

   · 

  5 min read